Compare OCS & BWIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OCS | BWIN |
|---|---|---|
| Founded | 2003 | 2011 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Specialty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.7B |
| IPO Year | N/A | 2019 |
| Metric | OCS | BWIN |
|---|---|---|
| Price | $28.40 | $22.88 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 5 |
| Target Price | ★ $39.57 | $34.00 |
| AVG Volume (30 Days) | 242.6K | ★ 1.2M |
| Earning Date | 03-10-2026 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $991,999.00 | ★ $1,487,497,000.00 |
| Revenue This Year | $14.53 | $10.94 |
| Revenue Next Year | $691.13 | $27.38 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 10.69 |
| 52 Week Low | $14.00 | $21.26 |
| 52 Week High | $28.01 | $47.15 |
| Indicator | OCS | BWIN |
|---|---|---|
| Relative Strength Index (RSI) | 84.73 | 36.26 |
| Support Level | $26.13 | $24.89 |
| Resistance Level | $27.43 | $26.82 |
| Average True Range (ATR) | 1.38 | 1.34 |
| MACD | 0.43 | -0.28 |
| Stochastic Oscillator | 91.00 | 2.11 |
Oculis Holding AG is a biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.
The Baldwin Insurance Group Inc is a United States-based insurance distribution firm. Its products include Business Insurance, Benefits Consulting, Reinsurance, Specialty MGA, Embedded Insurance., Personal insurance, etc.